ICMR receives proposal from NMCG to test Ganga water for Covid-19 treatment
Team Udayavani, May 4, 2020, 10:06 AM IST
Indian Medical Research Council (ICMR) has received a proposal to conduct clinical trials on Ganga water to examine if it can be used to treat patients infected with Covid-19.
The proposal was sent by The National Mission for Clean Ganga (NMCG), an arm of the Jal Shakti Ministry. It was forwarded after apex research body after Atulya Ganga, an organisation comprising Army Veterans, requested Ministry to conduct clinical trials on the holy water.
The letter submitted by Atulya Ganga claimed that there are several species of bacteriophages in the upper stretches of the Ganga.
“In Ganges, scientists have discovered bacteriophages, and named it Ninja Virus, popularly known as Gangtva. Phages, as they are also called, are viruses that specifically target bacteria and are also extremely strain specific,” it stated
Major Manoj Keshwar (retd), founder of Atulya Ganga said that India is blessed to have a holy river like Ganga and there are scientific references to suggest that these phages have anti-microbial properties and could potentially destroy bacteria.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Women centric schemes game-changer for Maharashtra, Jharkhand?
No anti-government sentiment in Kerala, claims CM Vijayan
Maharashtra poll results unexpected, incomprehensible: Uddhav Thackeray
Delhi Police constable stabbed to death in Govindpuri, one held
BJP snatches one Lok Sabha seat from Congress; Maharashtra win boosts Rajya Sabha majority prospects
MUST WATCH
Latest Additions
Satwik, Chirag doubles pair bows out of China Masters semifinals
Puttur: Two arrested for misconduct under influence of drugs
Kaup: Massive campaign and awareness rally Nov 26 for Constitution protection
Never entered into pact to operate airport in Kenya: Adani
Women centric schemes game-changer for Maharashtra, Jharkhand?
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.